| Year |
Title |
Altmetric |
| 2020
|
Macrophage Activation Syndrome and Secondary Hemophagocytic Lymphohistiocytosis in Childhood Inflammatory Disorders: Diagnosis and Management.
Pediatric Drugs.
22:29-44.
2020
|
|
| 2019
|
Characteristics of coexisting localized scleroderma and inflammatory arthritis..
European Journal of Rheumatology.
1-5.
2019
|
|
| 2019
|
Pediatric macrophage activation syndrome, recognizing the tip of the Iceberg..
European Journal of Rheumatology.
1-8.
2019
|
|
| 2019
|
Successful treatment of pediatric Tolosa-Hunt syndrome with adalimumab..
European Journal of Rheumatology.
1-3.
2019
|
|
| 2019
|
Patterns of B Cell Repletion Following Rituximab Therapy in a Pediatric Rheumatology Cohort..
Acr Open Rheumatology.
1:527-532.
2019
|
|
| 2019
|
Ferritin to Erythrocyte Sedimentation Rate Ratio: Simple Measure to Identify Macrophage Activation Syndrome in Systemic Juvenile Idiopathic Arthritis..
Acr Open Rheumatology.
1:345-349.
2019
|
|
| 2019
|
American College of Rheumatology Provisional Criteria for Clinically Relevant Improvement in Children and Adolescents With Childhood-Onset Systemic Lupus Erythematosus.
Arthritis Care and Research.
71:579-590.
2019
|
|
| 2019
|
Serum S100A8/A9 and S100A12 Levels in Children With Polyarticular Forms of Juvenile Idiopathic Arthritis: Relationship to Maintenance of Clinically Inactive Disease During Anti–Tumor Necrosis Factor Therapy and Occurrence of Disease Flare After Discontinuation of Therapy.
Arthritis and Rheumatology.
71:451-459.
2019
|
|
| 2019
|
Akkermansia muciniphila is permissive to arthritis in the K/BxN mouse model of arthritis.
Genes and Immunity.
20:158-166.
2019
|
|
| 2019
|
Alagille Syndrome and Chronic Arthritis: An International Case Series.
Journal of Pediatrics.
2019
|
|
| 2019
|
Benefit of Anakinra in Treating Pediatric Secondary Hemophagocytic Lymphohistiocytosis.
Arthritis and Rheumatology.
2019
|
|
| 2019
|
Development and initial validation of the MS score for diagnosis of macrophage activation syndrome in systemic juvenile idiopathic arthritis.
Annals of the Rheumatic Diseases.
78:1357-1362.
2019
|
|
| 2019
|
Emergent high fatality lung disease in systemic juvenile arthritis.
Annals of the Rheumatic Diseases.
78:1722-1731.
2019
|
|
| 2019
|
Standardizing terminology and assessment for orofacial conditions in juvenile idiopathic arthritis: International, multidisciplinary consensus-based recommendations.
Journal of Rheumatology.
46:518-522.
2019
|
|
| 2019
|
The immunology of macrophage activation syndrome.
Frontiers in Immunology.
10.
2019
|
|
| 2018
|
Rituximab treatment for chronic steroid-dependent Henoch-Schonlein purpura: 8 cases and a review of the literature.
Pediatric Rheumatology.
16.
2018
|
|
| 2018
|
Risk factors for intraarticular heterotopic bone formation in the temporomandibular joint in Juvenile idiopathic arthritis.
Journal of Rheumatology.
45:1301-1307.
2018
|
|
| 2018
|
Risk, Timing, and Predictors of Disease Flare After Discontinuation of Anti–Tumor Necrosis Factor Therapy in Children With Polyarticular Forms of Juvenile Idiopathic Arthritis With Clinically Inactive Disease.
Arthritis and Rheumatology.
70:1508-1518.
2018
|
|
| 2018
|
Brief Report: Novel UNC13D Intronic Variant Disrupting an NF-κB Enhancer in a Patient With Recurrent Macrophage Activation Syndrome and Systemic Juvenile Idiopathic Arthritis.
Arthritis and Rheumatology.
70:963-970.
2018
|
|
| 2018
|
Toward Establishing a Standardized Magnetic Resonance Imaging Scoring System for Temporomandibular Joints in Juvenile Idiopathic Arthritis.
Arthritis Care and Research.
70:758-767.
2018
|
|
| 2018
|
Effectiveness and safety of tofacitinib in rheumatoid arthritis: A cohort study.
Arthritis Research.
20.
2018
|
|
| 2018
|
Pediatric rheumatology infusion center: Report on therapeutic protocols and infusions given over 4 Years with focus on adverse events over 1 Year.
Pediatric Rheumatology.
16.
2018
|
|
| 2018
|
Effect of Biologic Therapy on Clinical and Laboratory Features of Macrophage Activation Syndrome Associated With Systemic Juvenile Idiopathic Arthritis.
Arthritis Care and Research.
70:409-419.
2018
|
|
| 2018
|
Regulatory CD4 T cells inhibit HIV-1 expression of other CD4 T cell subsets via interactions with cell surface regulatory proteins.
Virology.
516:21-29.
2018
|
|
| 2018
|
Smoking is the most significant modifiable lung cancer risk factor in systemic lupus erythematosus.
Journal of Rheumatology.
45:393-396.
2018
|
|
| 2018
|
Age and fecal microbial strain-specific differences in patients with spondyloarthritis.
Arthritis Research.
20.
2018
|
|
| 2018
|
Defining the normal appearance of the temporomandibular joints by magnetic resonance imaging with contrast: A comparative study of children with and without juvenile idiopathic arthritis.
Pediatric Rheumatology.
16.
2018
|
|
| 2018
|
Creating the Subspecialty Pediatrics Investigator Network.
Journal of Pediatrics.
192:3-4.e2.
2018
|
|
| 2018
|
Temporomandibular joint arthritis in juvenile idiopathic arthritis, now what?.
Pediatric Rheumatology.
16.
2018
|
|
| 2017
|
Risk of tuberculosis among Alabama children and adolescents treated with tumor necrosis factor inhibitors: A retrospective study.
Pediatric Rheumatology.
15.
2017
|
|
| 2017
|
Isolated arthritis of the temporomandibular joint as the initial manifestation of juvenile idiopathic arthritis.
Journal of Rheumatology.
44:1632-1635.
2017
|
|
| 2017
|
Development and Initial Validation of the Macrophage Activation Syndrome/Primary Hemophagocytic Lymphohistiocytosis Score, a Diagnostic Tool that Differentiates Primary Hemophagocytic Lymphohistiocytosis from Macrophage Activation Syndrome.
Journal of Pediatrics.
189:72-78.e3.
2017
|
|
| 2017
|
Malignancy in pediatric-onset systemic lupus erythematosus.
Journal of Rheumatology.
44:1484-1486.
2017
|
|
| 2017
|
Association of Anti–3-Hydroxy-3-Methylglutaryl-Coenzyme A Reductase Autoantibodies With DRB1*07:01 and Severe Myositis in Juvenile Myositis Patients.
Arthritis Care and Research.
69:1088-1094.
2017
|
|
| 2017
|
Weathering a macrophage storm.
Journal of Rheumatology.
44:970-972.
2017
|
|
| 2017
|
A review on SLE and malignancy.
Best Practice and Research: Clinical Rheumatology.
31:373-396.
2017
|
|
| 2017
|
CD4 regulatory T cells augment HIV-1 expression of polarized M1 and M2 monocyte derived macrophages.
Virology.
504:79-87.
2017
|
|
| 2017
|
Clinical orofacial examination in juvenile idiopathic arthritis: International consensus-based recommendations for monitoring patients in clinical practice and research studies.
Journal of Rheumatology.
44:326-333.
2017
|
|
| 2016
|
Fecal metabolomics in pediatric spondyloarthritis implicate decreased metabolic diversity and altered tryptophan metabolism as pathogenic factors.
Genes and Immunity.
17:400-405.
2016
|
|
| 2016
|
The microbiota in pediatric rheumatic disease: Epiphenomenon or therapeutic target?.
Current Opinion in Rheumatology.
28:537-543.
2016
|
|
| 2016
|
Ustekinumab as a Therapeutic Option for Children with Refractory Enthesitis-Related Arthritis.
JCR: Journal of Clinical Rheumatology.
22:282-284.
2016
|
|
| 2016
|
A heterozygous RAB27A mutation associated with delayed cytolytic granule polarization and hemophagocytic lymphohistiocytosis.
Journal of Immunology.
196:2492-2503.
2016
|
|
| 2016
|
2016 Classification Criteria for Macrophage Activation Syndrome Complicating Systemic Juvenile Idiopathic Arthritis: A European League Against Rheumatism/American College of Rheumatology/Paediatric Rheumatology International Trials Organisation Collaborative Initiative.
Arthritis and Rheumatology.
68:566-576.
2016
|
|
| 2016
|
2016 Classification criteria for macrophage activation syndrome complicating systemic juvenile idiopathic arthritis: A European league against Rheumatism/American college of Rheumatology/Paediatric rheumatology international trials organisation collaborative initiative.
Annals of the Rheumatic Diseases.
75:481-489.
2016
|
|
| 2016
|
Association of Myositis Autoantibodies, Clinical Features, and Environmental Exposures at Illness Onset with Disease Course in Juvenile Myositis.
Arthritis and Rheumatology.
68:761-768.
2016
|
|
| 2016
|
Interleukin-1 Receptor Blockade Is Associated with Reduced Mortality in Sepsis Patients with Features of Macrophage Activation Syndrome: Reanalysis of a Prior Phase III Trial∗.
Critical Care Medicine.
44:275-281.
2016
|
|
| 2016
|
Development of spondyloarthropathy following episodes of macrophage activation syndrome in children with heterozygous mutations in haemophagocytic lymphohistiocytosis-associated genes.
Clinical and Experimental Rheumatology.
34:953.
2016
|
|
| 2016
|
Expert consensus on dynamics of laboratory tests for diagnosis of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis.
RMD Open.
2.
2016
|
|
| 2016
|
Whole-exome sequencing reveals mutations in genes linked to hemophagocytic lymphohistiocytosis and macrophage activation syndrome in fatal cases of H1N1 influenza.
Journal of Infectious Diseases.
213:1180-1188.
2016
|
|
| 2015
|
Macrophage Activation Syndrome.
Hematology/Oncology Clinics of North America.
29:927-941.
2015
|
|
| 2015
|
Clinical features and correct diagnosis of macrophage activation syndrome.
Expert Review of Clinical Immunology.
11:1043-1053.
2015
|
|
| 2015
|
Dissecting the heterogeneity of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis.
Journal of Rheumatology.
42:994-1001.
2015
|
|
| 2015
|
Does viral hemorrhagic fever represent reactive hemophagocytic syndrome?.
Journal of Rheumatology.
42:1078-1080.
2015
|
|
| 2015
|
Kill or be killed.
Journal of Immunology.
194:5041-5043.
2015
|
|
| 2015
|
Magnetic resonance imaging findings following intraarticular infliximab therapy for refractory temporomandibular joint arthritis among children with juvenile idiopathic arthritis.
Journal of Rheumatology.
42:2155-2159.
2015
|
|
| 2015
|
Safety and efficacy of rituximab in childhood-onset systemic lupus erythematosus and other rheumatic diseases.
Journal of Rheumatology.
42:541-546.
2015
|
|
| 2015
|
Systemic and intra-articular anti-inflammatory therapy of temporomandibular joint arthritis in children with juvenile idiopathic arthritis.
Seminars in Orthodontics.
21:125-133.
2015
|
|
| 2015
|
Temporomandibular joint arthritis in juvenile idiopathic arthritis: The last frontier.
International Journal of Clinical Rheumatology.
10:273-285.
2015
|
|
| 2015
|
What investigations are needed to optimally monitor for malignancies in SLE?.
Lupus.
24:781-787.
2015
|
|
| 2014
|
High dose anakinra for treatment of severe neonatal Kawasaki disease: A case report.
Pediatric Rheumatology.
12.
2014
|
|
| 2014
|
Treatment of juvenile idiopathic arthritis: A revolution in care.
Pediatric Rheumatology.
12.
2014
|
|
| 2014
|
Results of a multinational survey regarding the diagnosis and treatment of temporomandibular joint involvement in juvenile idiopathic arthritis.
Pediatric Rheumatology.
12.
2014
|
|
| 2014
|
Altered microbiota associated with abnormal humoral immune responses to commensal organisms in enthesitis-related arthritis.
Arthritis Research.
16:486.
2014
|
|
| 2014
|
Changes in body mass index in children with juvenile idiopathic arthritis treated with tumor necrosis factor inhibitors.
Journal of Rheumatology.
41:113-118.
2014
|
|
| 2014
|
Clinical features, treatment, and outcome of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis: A multinational, multicenter study of 362 patients.
Arthritis and Rheumatology.
66:3160-3169.
2014
|
|
| 2014
|
Genetic Defects in Cytolysis in Macrophage Activation Syndrome.
Current Rheumatology Reports.
16.
2014
|
|
| 2014
|
IL-15 prolongs CD154 expression on human CD4 T cells via STAT5 binding to the CD154 transcriptional promoter.
Genes and Immunity.
15:137-144.
2014
|
|
| 2014
|
Imaging of the temporomandibular joint in juvenile idiopathic arthritis.
Arthritis Care and Research.
66:47-54.
2014
|
|
| 2014
|
Kinase control of latent HIV-1 infection: PIM-1 kinase as a major contributor to HIV-1 reactivation.
Journal of Virology.
88:364-376.
2014
|
|
| 2014
|
Performance of current guidelines for diagnosis of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis.
Arthritis and Rheumatology.
66:2871-2880.
2014
|
|
| 2014
|
Systemic lupus erythematosus and malignancies: A review article.
Rheumatic Disease Clinics of North America.
40:497-506.
2014
|
|
| 2014
|
The impact of Nucleofection® on the activation state of primary human CD4 T cells.
Journal of Immunological Methods.
408:123-131.
2014
|
|
| 2013
|
Cancer risk in childhood-onset systemic lupus.
Arthritis Research.
15.
2013
|
|
| 2013
|
Treatment of Juvenile Idiopathic Arthritis in the Biologic Age.
Rheumatic Disease Clinics of North America.
39:751-766.
2013
|
|
| 2013
|
High doses of infliximab in the management of juvenile idiopathic arthritis.
Journal of Rheumatology.
40:1749-1755.
2013
|
|
| 2013
|
MHCII is required for α-Synuclein-induced activation of microglia, CD4 T cell proliferation, and dopaminergic neurodegeneration.
Journal of Neuroscience.
33:9592-9600.
2013
|
|
| 2013
|
Retinal vasculitis in two pediatric patients with systemic lupus erythematosus: A case report.
Pediatric Rheumatology.
11.
2013
|
|
| 2013
|
Condylar Degeneration and Diseases-Local and Systemic Etiologies.
Seminars in Orthodontics.
19:89-96.
2013
|
|
| 2013
|
Higher-dose anakinra is effective in a case of medically refractory macrophage activation syndrome.
Journal of Rheumatology.
40:743-744.
2013
|
|
| 2013
|
Anaphylaxis to etanercept in two children with juvenile idiopathic arthritis.
JCR: Journal of Clinical Rheumatology.
19:129-131.
2013
|
|
| 2013
|
Safety and efficacy of intra-articular infliximab therapy for treatment-resistant temporomandibular joint arthritis in children: A retrospective study.
Rheumatology.
52:554-559.
2013
|
|
| 2013
|
An AP-1 binding site in the enhancer/core element of the HIV-1 promoter controls the ability of HIV-1 to establish latent infection.
Journal of Virology.
87:2264-2277.
2013
|
|
| 2012
|
Host factor transcriptional regulation contributes to preferential expression of HIV type 1 in IL-4-producing CD4 T cells.
Journal of Immunology.
189:2746-2757.
2012
|
|
| 2012
|
Intensive care requirement, rather than degree of serum ferritin elevation, predicts mortality in macrophage activation syndrome.
Pediatric Critical Care Medicine.
13:616.
2012
|
|
| 2012
|
Risk factors for temporomandibular joint arthritis in children with juvenile idiopathic arthritis.
Journal of Rheumatology.
39:1880-1887.
2012
|
|
| 2012
|
Management of temporomandibular joint arthritis in adult rheumatology practices: a survey of adult rheumatologists.
Pediatric Rheumatology.
10.
2012
|
|
| 2012
|
Intra-articular corticosteroid injections to the temporomandibular joints are safe and appear to be effective therapy in children with juvenile idiopathic arthritis.
Journal of Oral and Maxillofacial Surgery.
70:1802-1807.
2012
|
|
| 2012
|
Macrophage activation syndrome as part of systemic juvenile idiopathic arthritis: Diagnosis, genetics, pathophysiology and treatment.
Genes and Immunity.
13:289-298.
2012
|
|
| 2012
|
NF-ATc1 levels are increased in murine and human lupus T cells: Comment on the article by kyttaris et al.
Arthritis and Rheumatism.
64:1294.
2012
|
|
| 2011
|
Attainment of inactive disease status following initiation of TNF-α inhibitor therapy for juvenile idiopathic arthritis: Enthesitis-related arthritis predicts persistent active disease.
Journal of Rheumatology.
38:2675-2681.
2011
|
|
| 2011
|
Temporomandibular joint arthritis in pediatric Sjögren disease and sarcoidosis.
Journal of Rheumatology.
38:2272-2273.
2011
|
|
| 2011
|
Reply.
Arthritis Care and Research.
63:1355.
2011
|
|
| 2011
|
High prevalence of myositis in a southeastern United States pediatric systemic lupus erythematosus cohort.
Pediatric Rheumatology.
9.
2011
|
|
| 2011
|
Brain cavernomas associated with en coup de sabre linear scleroderma: Two case reports.
Pediatric Rheumatology.
9.
2011
|
|
| 2011
|
1.5 Decades Later: Bearing fruits from the ACR/EULAR exchange Program.
Pediatric Rheumatology.
9.
2011
|
|
| 2011
|
2011 American College of Rheumatology recommendations for the treatment of juvenile idiopathic arthritis: initiation and safety monitoring of therapeutic agents for the treatment of arthritis and systemic features..
Arthritis Care and Research.
63:465-482.
2011
|
|
| 2011
|
An international consensus survey of diagnostic criteria for macrophage activation syndrome in systemic juvenile idiopathic arthritis.
Journal of Rheumatology.
38:764-768.
2011
|
|
| 2011
|
Anakinra as first-line disease-modifying therapy in systemic juvenile idiopathic arthritis: Report of forty-six patients from an international multicenter series.
Arthritis and Rheumatism.
63:545-555.
2011
|
|
| 2011
|
Corticosteroid-induced spinal epidural lipomatosis in the pediatric age group: Report of a new case and updated analysis of the literature.
Pediatric Rheumatology.
9.
2011
|
|
| 2011
|
Successful treatment of severe paediatric rheumatic disease-associated macrophage activation syndrome with interleukin-1 inhibition following conventional immunosuppressive therapy: Case series with 12 patients.
Rheumatology.
50:417-419.
2011
|
|
| 2011
|
Successful treatment of pediatric IgG4 related systemic disease with mycophenolate mofetil: Case report and a review of the pediatric autoimmune pancreatitis literature.
Pediatric Rheumatology.
9.
2011
|
|
| 2011
|
Combination therapy of abatacept and in children with refractory systemic juvenile idiopathic arthritis: A retrospective case series.
Journal of Rheumatology.
38:180-181.
2011
|
|
| 2010
|
Guilt by association - what is the true risk of malignancy in children treated with etanercept for JIA?.
Pediatric Rheumatology.
8.
2010
|
|
| 2010
|
Prolonged expression of CD154 on CD4 T cells from pediatric lupus patients correlates with increased CD154 transcription, increased nuclear factor of activated T cell activity, and glomerulonephritis.
Arthritis and Rheumatism.
62:2499-2509.
2010
|
|
| 2010
|
Effectiveness and toxicity of methotrexate in juvenile idiopathic arthritis: Comparison of 2 initial dosing regimens.
Journal of Rheumatology.
37:870-875.
2010
|
|
| 2009
|
FOXP3 inhibits activation-induced NFAT2 expression in T cells thereby limiting effector cytokine expression.
Journal of Immunology.
183:907-915.
2009
|
|
| 2009
|
Rituximab Therapy for Severe Refractory Chronic Henoch-Schönlein Purpura.
Journal of Pediatrics.
155:136-139.
2009
|
|
| 2009
|
The temporomandibular joint in juvenile idiopathic arthritis: Frequently used and frequently arthritic.
Pediatric Rheumatology.
7.
2009
|
|
| 2009
|
Determinants of the Establishment of Human Immunodeficiency Virus Type 1 Latency.
Journal of Virology.
83:3078-3093.
2009
|
|
| 2009
|
Rheumatology fellows' perception on training and careers in academia: The american college of rheumatology fellow research and academic training survey.
Arthritis Care and Research.
61:266-273.
2009
|
|
| 2008
|
FOXP3 inhibits HIV-1 infection of CD4 T-cells via inhibition of LTR transcriptional activity.
Virology.
381:161-167.
2008
|
|
| 2008
|
A T-cell-specific CD154 transcriptional enhancer located just upstream of the promoter.
Genes and Immunity.
9:640-649.
2008
|
|
| 2008
|
High prevalence of temporomandibular joint arthritis at disease onset in children with juvenile idiopathic arthritis, as detected by magnetic resonance imaging but not by ultrasound.
Arthritis and Rheumatism.
58:1189-1196.
2008
|
|
| 2008
|
Research priorities in pediatric rheumatology: The Childhood Arthritis and Rheumatology Research Alliance (CARRA) consensus.
Pediatric Rheumatology.
6.
2008
|
|
| 2008
|
Evaluation of the presentation of systemic onset juvenile rheumatoid arthritis: Data from the Pennsylvania Systemic Onset Juvenile Arthritis Registry (PASOJAR).
Journal of Rheumatology.
35:343-348.
2008
|
|
| 2008
|
Neither cell-surface nor soluble CD154 levels are associated with coronary artery disease in systemic lupus erythematosus.
Journal of Rheumatology.
35:359-360.
2008
|
|
| 2007
|
Pediatric rheumatology for the adult rheumatologist II: Uveitis in juvenile idiopathic arthritis.
JCR: Journal of Clinical Rheumatology.
13:205-210.
2007
|
|
| 2007
|
Benefit of fluoroscopically guided intraarticular, long-acting corticosteroid injection for subtalar arthritis in juvenile idiopathic arthritis.
Pediatric Radiology.
37:544-548.
2007
|
|
| 2007
|
Occult macrophage activation syndrome in patients with systemic juvenile idiopathic arthritis.
Journal of Rheumatology.
34:1133-1138.
2007
|
|
| 2007
|
Reactive arthritis of the temporomandibular joints and cervical spine in a child.
Pediatric Rheumatology.
5.
2007
|
|
| 2007
|
CT-guided percutaneous steroid injection for management of inflammatory arthropathy of the temporomandibular joint in children.
American Journal of Roentgenology.
188:182-186.
2007
|
|
| 2007
|
Juvenile idiopathic arthritis classification criteria: Loopholes and diagnosis software [3].
Journal of Rheumatology.
34:234.
2007
|
|
| 2006
|
Benefit of intraarticular corticosteroid injection under fluoroscopic guidance for subtalar arthritis in juvenile idiopathic arthritis.
Journal of Rheumatology.
33:2330-2336.
2006
|
|
| 2006
|
Picture of the month: anaplastic large cell lymphoma with hemophagocytic lymphohistiocytosis..
Archives of Pediatrics and Adolescent Medicine.
160:1177-1179.
2006
|
|
| 2006
|
Interleukin 1 receptor antagonist to treat cytophagic histiocytic panniculitis with secondary hemophagocytic lymphohistiocytosis.
Journal of Rheumatology.
33:2081-2084.
2006
|
|
| 2006
|
Sjögren syndrome in a child: Favorable response of the arthritis to TNFα blockade.
Clinical Rheumatology.
25:746-748.
2006
|
|
| 2006
|
Temporomandibular joint arthritis in juvenile idiopathic arthritis: The forgotten joint.
Current Opinion in Rheumatology.
18:490-495.
2006
|
|
| 2006
|
Chronic arthritis without uveitis in velocardiofacial syndrome.
Journal of Pediatrics.
149:281.
2006
|
|
| 2006
|
Homocysteine levels and disease duration independently correlate with coronary artery calcification in patients with systemic lupus erythematosus.
Arthritis and Rheumatism.
54:2220-2227.
2006
|
|
| 2006
|
Effective gene suppression using small interfering RNA in hard-to-transfect human T cells.
Journal of Immunological Methods.
312:1-11.
2006
|
|
| 2006
|
Septic abscess in a child with juvenile idiopathic arthritis receiving anti-tumor necrosis factor-α therapy [1].
Journal of Rheumatology.
33:825.
2006
|
|
| 2006
|
Treatment of pediatric localized scleroderma with methotrexate.
Journal of Rheumatology.
33:609-614.
2006
|
|
| 2006
|
The γc-cytokine regulated transcription factor, STAT5, increases HIV-1 production in primary CD4 T cells.
Virology.
344:283-291.
2006
|
|
| 2006
|
Early growth response-1 is required for CD154 transcription.
Journal of Immunology.
176:811-818.
2006
|
|
| 2006
|
NFAT transcription factors - New players in the pathogenesis of inflammatory arthropathies?.
Autoimmunity Reviews.
5:106-110.
2006
|
|
| 2006
|
Picture of the month.
Archives of Pediatrics and Adolescent Medicine.
160:1177-1179.
2006
|
|
| 2006
|
The spectrum of renal tubular acidosis in paediatric Sjögren syndrome.
Rheumatology.
45:85-91.
2006
|
|
| 2005
|
Sweet syndrome as an initial presentation in a child with systemic lupus erythematosus [1].
Lupus.
14:974-975.
2005
|
|
| 2005
|
Utility of corticosteroid injection for temporomandibular arthritis in children with juvenile idiopathic arthritis.
Arthritis and Rheumatism.
52:3563-3569.
2005
|
|
| 2005
|
Editorial: A signal achievement in the treatment of arthritis.
Arthritis and Rheumatism.
52:2229-2232.
2005
|
|
| 2005
|
Pediatric rheumatology for the adult rheumatologist I: Therapy and dosing for pediatric rheumatic disorders.
JCR: Journal of Clinical Rheumatology.
11:21-33.
2005
|
|
| 2004
|
Reciprocal regulation of the nuclear factor of activated T cells and HIV-1.
Genes and Immunity.
5:158-167.
2004
|
|
| 2004
|
Overexpression of octamer transcription factors 1 or 2 alone has no effect on HIV-1 transcription in primary human CD4 T cells.
Virology.
321:323-331.
2004
|
|
| 2003
|
Decreased CD154 expression by neonatal CD4+ T cells is due to limitations in both proximal and distal events of T cells activation.
International Immunology.
15:1461-1472.
2003
|
|
| 2003
|
Methotrexate used as a steroid-sparing agent in non-renal chronic Henoch-Schönlein purpura.
Clinical and Experimental Rheumatology.
21:767-769.
2003
|
|
| 2003
|
Erratum: Delineation of a novel pathway that regulates CD154 (CD40 ligand) expression (Molecular and Cellular Biology (2003) 23:2 (510-525)).
Molecular and Cellular Biology.
23:6338.
2003
|
|
| 2003
|
CD154 transcriptional regulation in primary human CD4 T cells.
Immunologic Research.
27:185-202.
2003
|
|
| 2003
|
Delineation of a novel pathway that regulates CD154 (CD40 ligand) expression.
Molecular and Cellular Biology.
23:510-525.
2003
|
|
| 2002
|
Current treatment for chronic arthritis in childhood.
Current Opinion in Pediatrics.
14:684-687.
2002
|
|
| 2002
|
Regulation of the murine Nfatc1 gene by NFATc2.
Journal of Biological Chemistry.
277:10704-10711.
2002
|
|
| 2002
|
HIV-1, NFAT, and cyclosporin: Immunosuppression for the immunosuppressed?.
DNA (Mary Ann Liebert, Inc.).
20:761-767.
2002
|
|
| 2002
|
A T cell-specific enhancer of the human CD40 ligand gene.
Journal of Biological Chemistry.
277:7386-7395.
2002
|
|
| 2001
|
Octamer proteins inhibit IL-4 gene transcription in normal human CD4 T cells.
Genes and Immunity.
2:464-468.
2001
|
|
| 2001
|
Treatment for JRA in the new millennium.
JCR: Journal of Clinical Rheumatology.
7:283-285.
2001
|
|
| 2000
|
Nabumetone induced pseudoporphyria in childhood [3] (multiple letters).
Journal of Rheumatology.
27:1817-1818.
2000
|
|
| 2000
|
Nabumetone induced pseudoporphyria in childhood..
Journal of Rheumatology.
27:1817-1818.
2000
|
|
| 2000
|
NFAT1 enhances HIV-1 gene expression in primary human CD4 T cells.
Clinical Immunology.
94:179-191.
2000
|
|
| 1999
|
Current treatment by United States and Canadian pediatric rheumatologists.
Journal of Rheumatology.
26:2036-2038.
1999
|
|
| 1999
|
T cell priming enhances IL-4 gene expression by increasing nuclear factor of activated T cells.
Journal of Immunology.
162:860-870.
1999
|
|
| 1998
|
Methotrexate-induced hypersensitivity pneumonitis in a child with juvenile rheumatoid arthritis.
Journal of Pediatrics.
132:901-902.
1998
|
|
| 1997
|
Childhood sarcoidosis--does age of onset predict clinical manifestations?.
Journal of Rheumatology.
24:1654-1656.
1997
|
|
| 1997
|
Consistent transient transfection of DNA into non-transformed human and murine T-lymphocytes.
Journal of Immunological Methods.
205:145-150.
1997
|
|
| 1997
|
Reactive arthritis to Clostridium difficile in a child.
Western Journal of Medicine.
166:419-421.
1997
|
|
| 1996
|
Picture of the month. Polyarteritis nodosa with angioedema..
Archives of Pediatrics and Adolescent Medicine.
150:875-876.
1996
|
|
| 1996
|
Picture of the month.
Archives of Pediatrics and Adolescent Medicine.
150:875-876.
1996
|
|
| 1996
|
Reiter syndrome initially misdiagnosed as Kawasaki disease.
Journal of Pediatrics.
128:366-369.
1996
|
|
| 1995
|
The human gp39 promoter: Two distinct nuclear factors of activated T cell protein-binding elements contribute independently to transcriptional activation.
Journal of Biological Chemistry.
270:29624-29627.
1995
|
|
| 1995
|
Index of suspicion. Case 2. Diagnosis: peritonsillitis..
Pediatrics in Review.
16:117-119.
1995
|
|
| 1995
|
Necrobacillosis: An unusual cause of purulent otitis media and sepsis.
Pediatric Emergency Care.
11:379-380.
1995
|
|
| 1995
|
Reiter's syndrome associated with cryptosporidial gastroenteritis.
Journal of Rheumatology.
22:1962-1963.
1995
|
|
| 1994
|
Differential effects of T cell receptor ligation of TCRγδ thymocyte development in fetal thymic organ culture.
Thymus.
23:131-153.
1994
|
|
| 1994
|
Scleredema Revisited: A Poststreptococcal Complication.
Clinical Pediatrics.
33:606-610.
1994
|
|
| 1992
|
Peripheral T cell receptor γδ variable gene repertoire maps to the T cell receptor loci and is influenced by positive selection.
Journal of Immunology.
149:3200-3207.
1992
|
|
| 1991
|
Ligand specificity and repertoire development of murine TCRγδ cells.
Current Topics in Microbiology and Immunology.
173:133-139.
1991
|
|
| 1991
|
Repertoire Development and Ligand Specificity of Murine TCRγδ Cells.
Immunological Reviews.
120:5-33.
1991
|
|
| 1990
|
Polymorphisms and diversity of T-cell receptor-γ proteins expressed in mouse spleen.
Immunogenetics.
31:220-228.
1990
|
|
| 1990
|
Freshly isolated Thy-1+ dendritic epidermal cells express T cell receptor γδ-CD3.
Journal of Dermatological Science.
1:459-464.
1990
|
|
| 1990
|
T cell receptor δ-gene expression and diversity in the mouse spleen.
Journal of Immunology.
145:1311-1317.
1990
|
|
| 1989
|
A TCR gamma delta cell recognizing a novel TL-encoded gene product..
Cold Spring Harbor Symposia on Quantitative Biology.
54 Pt 1:45-55.
1989
|
|
| 1989
|
Identification of distinct T cell receptor (TCR)-γδ heterodimers using an anti-TCR-γ variable region serum.
Journal of Immunology.
143:3769-3775.
1989
|
|
| 1989
|
Phenotypic and functional analysis of murine CD3+, CD4-, CD8- TCR-γδ-expressing peripheral T cells.
Journal of Immunology.
142:3754-3762.
1989
|
|
| 1989
|
Structure and specificity of a class II MHC alloreactive γδ T cell receptor heterodimer.
Science.
245:746-749.
1989
|
|
| 1988
|
Systematic development of distinct T cell receptor-γδ T cell subsets during fetal ontogeny.
Journal of Immunology.
141:3753-3759.
1988
|
|
| 1988
|
Structure and specificity of T cell receptor γ/δ on major histocompatibility complex antigen-specific CD3+, CD4−, CD8− T lymphocytes.
Journal of Experimental Medicine.
168:1899-1916.
1988
|
|
| 1988
|
Peripheral murine CD3+, CD4-, CD8- T lymphocytes express novel T cell receptor gamma delta structures..
Journal of Immunology.
141:1074-1082.
1988
|
|
| 1988
|
Peripheral murine CD3+, CD4-, CD8- T lymphocytes express novel T cell receptor γδ structures.
Journal of Immunology.
141:1074-1082.
1988
|
|
| 1987
|
Major histocompatibility complex-linked specificity of γδ receptor-bearing T lymphocytes.
Nature.
330:262-264.
1987
|
|
